Preferred Name |
suvorexant |
|
Synonyms |
MK-4305 methanone, ((7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)- MK 4305 (4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone MK4305 Belsomra |
|
ID |
http://purl.bioontology.org/ontology/MESH/C551624 |
|
altLabel |
MK-4305 methanone, ((7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)- MK 4305 (4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone MK4305 Belsomra |
|
cui |
C3179535 C2936053 C3854974 |
|
HM |
D014230 D001381 |
|
Inverse of RB |
081L192FO9 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20100824 |
|
MeSH Frequency |
198 |
|
MMR |
20150927 |
|
notation |
C551624 |
|
PA |
D000068776 D000068796 |
|
prefLabel |
suvorexant |
|
SC |
1 |
|
Scope Statement |
an orexin receptor antagonist; structure in first source |
|
SRC |
J Med Chem 2010 Jul 22;53(14):5320-32 |
|
TERMUI |
T000877022 T000877023 T000877024 T776203 T776205 T776204 T776202 |
|
TH |
NLM (2015) USAN (19XX) INN (19XX) NLM (2010) FDA SRS (2015) |
|
tui |
T109 T121 |